SARS-CoV-2 Disease through Viral Genomic and Receptor Implications: An Overview of Diagnostic and Immunology Breakthroughs

The SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), which is believed to have originated in China towards the end of November 2019, has now spread across the globe, causing a pandemic in 192 countries. The World Health Organization has called it the SARS-CoV-2 pandemic. Rapid dissemina...

Full description

Bibliographic Details
Main Authors: Alessio Danilo Inchingolo, Angelo Michele Inchingolo, Ioana Roxana Bordea, Giuseppina Malcangi, Edit Xhajanka, Antonio Scarano, Felice Lorusso, Marco Farronato, Gianluca Martino Tartaglia, Ciro Gargiulo Isacco, Grazia Marinelli, Maria Teresa D’Oria, Denisa Hazballa, Luigi Santacroce, Andrea Ballini, Maria Contaldo, Francesco Inchingolo, Gianna Dipalma
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Microorganisms
Subjects:
Online Access:https://www.mdpi.com/2076-2607/9/4/793
_version_ 1827695438030962688
author Alessio Danilo Inchingolo
Angelo Michele Inchingolo
Ioana Roxana Bordea
Giuseppina Malcangi
Edit Xhajanka
Antonio Scarano
Felice Lorusso
Marco Farronato
Gianluca Martino Tartaglia
Ciro Gargiulo Isacco
Grazia Marinelli
Maria Teresa D’Oria
Denisa Hazballa
Luigi Santacroce
Andrea Ballini
Maria Contaldo
Francesco Inchingolo
Gianna Dipalma
author_facet Alessio Danilo Inchingolo
Angelo Michele Inchingolo
Ioana Roxana Bordea
Giuseppina Malcangi
Edit Xhajanka
Antonio Scarano
Felice Lorusso
Marco Farronato
Gianluca Martino Tartaglia
Ciro Gargiulo Isacco
Grazia Marinelli
Maria Teresa D’Oria
Denisa Hazballa
Luigi Santacroce
Andrea Ballini
Maria Contaldo
Francesco Inchingolo
Gianna Dipalma
author_sort Alessio Danilo Inchingolo
collection DOAJ
description The SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), which is believed to have originated in China towards the end of November 2019, has now spread across the globe, causing a pandemic in 192 countries. The World Health Organization has called it the SARS-CoV-2 pandemic. Rapid dissemination of the virus occurs mainly through the saliva (Flügge’s droplets) and aerosol, together with nasal and lachrymal passages. The literature associated with the recent advancement in terms of rapid diagnostics and SARS-CoV-2 vaccines has thoroughly studied the role of ACE2 receptors and Furin, as well as viral agent access into the host cell and its significant persistence at the level of the oral mucosa, which represents the main access to the virus. The purpose of this review was to underline the processes of SARS-CoV-2 infection mechanisms and novel breakthroughs in diagnostics and vaccines. Different technologies, such as the RT-PCR molecular test and the antigenic test, have been developed to identify subjects affected by the SARS-CoV-2 in order to improve the tracking of infection geographical diffusion. Novel rapid and highly sensitive diagnostic tests has been proposed for the detection of SARS-CoV-2 to improve the screening capability of suspected contagions. The strengthening of the vaccination campaign represents the most effective means to combat the SARS-CoV-2 infection and prevent severe manifestations of the virus—different classes of vaccines have been developed for this purpose. Further attention on the novel SARS-CoV-2 variant is necessary in order to verify the protection efficacy and virulence reduction of the infective agent in the recent vaccine campaign.
first_indexed 2024-03-10T12:27:19Z
format Article
id doaj.art-b3da48cc354d469499a3b6c3c5189e6a
institution Directory Open Access Journal
issn 2076-2607
language English
last_indexed 2024-03-10T12:27:19Z
publishDate 2021-04-01
publisher MDPI AG
record_format Article
series Microorganisms
spelling doaj.art-b3da48cc354d469499a3b6c3c5189e6a2023-11-21T14:59:30ZengMDPI AGMicroorganisms2076-26072021-04-019479310.3390/microorganisms9040793SARS-CoV-2 Disease through Viral Genomic and Receptor Implications: An Overview of Diagnostic and Immunology BreakthroughsAlessio Danilo Inchingolo0Angelo Michele Inchingolo1Ioana Roxana Bordea2Giuseppina Malcangi3Edit Xhajanka4Antonio Scarano5Felice Lorusso6Marco Farronato7Gianluca Martino Tartaglia8Ciro Gargiulo Isacco9Grazia Marinelli10Maria Teresa D’Oria11Denisa Hazballa12Luigi Santacroce13Andrea Ballini14Maria Contaldo15Francesco Inchingolo16Gianna Dipalma17Department of Interdisciplinary Medicine, University of Medicine Aldo Moro, 70124 Bari, ItalyDepartment of Interdisciplinary Medicine, University of Medicine Aldo Moro, 70124 Bari, ItalyDepartment of Oral Rehabilitation, Faculty of Dentistry, Iuliu Hațieganu University of Medicine and Pharmacy, 400012 Cluj-Napoca, RomaniaDepartment of Interdisciplinary Medicine, University of Medicine Aldo Moro, 70124 Bari, ItalyDepartment of Dental Prosthesis, Medical University of Tirana, Rruga e Dibrës, U.M.T., 1001 Tirana, AlbaniaDepartment of Innovative Technologies in Medicine and Dentistry, University of Chieti-Pescara, 66100 Chieti, ItalyDepartment of Innovative Technologies in Medicine and Dentistry, University of Chieti-Pescara, 66100 Chieti, ItalyUOC Maxillo-Facial Surgery and Dentistry, Department of Biomedical, Surgical and Dental Sciences, School of Dentistry, Fondazione IRCCS Ca Granda, Ospedale Maggiore Policlinico, University of Milan, 20100 Milan, ItalyUOC Maxillo-Facial Surgery and Dentistry, Department of Biomedical, Surgical and Dental Sciences, School of Dentistry, Fondazione IRCCS Ca Granda, Ospedale Maggiore Policlinico, University of Milan, 20100 Milan, ItalyDepartment of Interdisciplinary Medicine, University of Medicine Aldo Moro, 70124 Bari, ItalyDepartment of Interdisciplinary Medicine, University of Medicine Aldo Moro, 70124 Bari, ItalyDepartment of Interdisciplinary Medicine, University of Medicine Aldo Moro, 70124 Bari, ItalyDepartment of Interdisciplinary Medicine, University of Medicine Aldo Moro, 70124 Bari, ItalyDepartment of Interdisciplinary Medicine, University of Medicine Aldo Moro, 70124 Bari, ItalyDepartment of Biosciences, Biotechnologies and Biopharmaceutics, Campus Universitario Ernesto Quagliariello, University of Bari “Aldo Moro”, 70125 Bari, ItalyMultidisciplinary Department of Medical-Surgical and Dental Specialties, University of Campania Luigi Vanvitelli, Via Luigi de Crecchio, 6, 80138 Naples, ItalyDepartment of Interdisciplinary Medicine, University of Medicine Aldo Moro, 70124 Bari, ItalyDepartment of Interdisciplinary Medicine, University of Medicine Aldo Moro, 70124 Bari, ItalyThe SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), which is believed to have originated in China towards the end of November 2019, has now spread across the globe, causing a pandemic in 192 countries. The World Health Organization has called it the SARS-CoV-2 pandemic. Rapid dissemination of the virus occurs mainly through the saliva (Flügge’s droplets) and aerosol, together with nasal and lachrymal passages. The literature associated with the recent advancement in terms of rapid diagnostics and SARS-CoV-2 vaccines has thoroughly studied the role of ACE2 receptors and Furin, as well as viral agent access into the host cell and its significant persistence at the level of the oral mucosa, which represents the main access to the virus. The purpose of this review was to underline the processes of SARS-CoV-2 infection mechanisms and novel breakthroughs in diagnostics and vaccines. Different technologies, such as the RT-PCR molecular test and the antigenic test, have been developed to identify subjects affected by the SARS-CoV-2 in order to improve the tracking of infection geographical diffusion. Novel rapid and highly sensitive diagnostic tests has been proposed for the detection of SARS-CoV-2 to improve the screening capability of suspected contagions. The strengthening of the vaccination campaign represents the most effective means to combat the SARS-CoV-2 infection and prevent severe manifestations of the virus—different classes of vaccines have been developed for this purpose. Further attention on the novel SARS-CoV-2 variant is necessary in order to verify the protection efficacy and virulence reduction of the infective agent in the recent vaccine campaign.https://www.mdpi.com/2076-2607/9/4/793SARS-CoV-2 (COVID-19 pandemic)ACE2TMPRSS2oral mucosa (salivary glands)furinCytokine Storm Syndrome (CSS)
spellingShingle Alessio Danilo Inchingolo
Angelo Michele Inchingolo
Ioana Roxana Bordea
Giuseppina Malcangi
Edit Xhajanka
Antonio Scarano
Felice Lorusso
Marco Farronato
Gianluca Martino Tartaglia
Ciro Gargiulo Isacco
Grazia Marinelli
Maria Teresa D’Oria
Denisa Hazballa
Luigi Santacroce
Andrea Ballini
Maria Contaldo
Francesco Inchingolo
Gianna Dipalma
SARS-CoV-2 Disease through Viral Genomic and Receptor Implications: An Overview of Diagnostic and Immunology Breakthroughs
Microorganisms
SARS-CoV-2 (COVID-19 pandemic)
ACE2
TMPRSS2
oral mucosa (salivary glands)
furin
Cytokine Storm Syndrome (CSS)
title SARS-CoV-2 Disease through Viral Genomic and Receptor Implications: An Overview of Diagnostic and Immunology Breakthroughs
title_full SARS-CoV-2 Disease through Viral Genomic and Receptor Implications: An Overview of Diagnostic and Immunology Breakthroughs
title_fullStr SARS-CoV-2 Disease through Viral Genomic and Receptor Implications: An Overview of Diagnostic and Immunology Breakthroughs
title_full_unstemmed SARS-CoV-2 Disease through Viral Genomic and Receptor Implications: An Overview of Diagnostic and Immunology Breakthroughs
title_short SARS-CoV-2 Disease through Viral Genomic and Receptor Implications: An Overview of Diagnostic and Immunology Breakthroughs
title_sort sars cov 2 disease through viral genomic and receptor implications an overview of diagnostic and immunology breakthroughs
topic SARS-CoV-2 (COVID-19 pandemic)
ACE2
TMPRSS2
oral mucosa (salivary glands)
furin
Cytokine Storm Syndrome (CSS)
url https://www.mdpi.com/2076-2607/9/4/793
work_keys_str_mv AT alessiodaniloinchingolo sarscov2diseasethroughviralgenomicandreceptorimplicationsanoverviewofdiagnosticandimmunologybreakthroughs
AT angelomicheleinchingolo sarscov2diseasethroughviralgenomicandreceptorimplicationsanoverviewofdiagnosticandimmunologybreakthroughs
AT ioanaroxanabordea sarscov2diseasethroughviralgenomicandreceptorimplicationsanoverviewofdiagnosticandimmunologybreakthroughs
AT giuseppinamalcangi sarscov2diseasethroughviralgenomicandreceptorimplicationsanoverviewofdiagnosticandimmunologybreakthroughs
AT editxhajanka sarscov2diseasethroughviralgenomicandreceptorimplicationsanoverviewofdiagnosticandimmunologybreakthroughs
AT antonioscarano sarscov2diseasethroughviralgenomicandreceptorimplicationsanoverviewofdiagnosticandimmunologybreakthroughs
AT felicelorusso sarscov2diseasethroughviralgenomicandreceptorimplicationsanoverviewofdiagnosticandimmunologybreakthroughs
AT marcofarronato sarscov2diseasethroughviralgenomicandreceptorimplicationsanoverviewofdiagnosticandimmunologybreakthroughs
AT gianlucamartinotartaglia sarscov2diseasethroughviralgenomicandreceptorimplicationsanoverviewofdiagnosticandimmunologybreakthroughs
AT cirogargiuloisacco sarscov2diseasethroughviralgenomicandreceptorimplicationsanoverviewofdiagnosticandimmunologybreakthroughs
AT graziamarinelli sarscov2diseasethroughviralgenomicandreceptorimplicationsanoverviewofdiagnosticandimmunologybreakthroughs
AT mariateresadoria sarscov2diseasethroughviralgenomicandreceptorimplicationsanoverviewofdiagnosticandimmunologybreakthroughs
AT denisahazballa sarscov2diseasethroughviralgenomicandreceptorimplicationsanoverviewofdiagnosticandimmunologybreakthroughs
AT luigisantacroce sarscov2diseasethroughviralgenomicandreceptorimplicationsanoverviewofdiagnosticandimmunologybreakthroughs
AT andreaballini sarscov2diseasethroughviralgenomicandreceptorimplicationsanoverviewofdiagnosticandimmunologybreakthroughs
AT mariacontaldo sarscov2diseasethroughviralgenomicandreceptorimplicationsanoverviewofdiagnosticandimmunologybreakthroughs
AT francescoinchingolo sarscov2diseasethroughviralgenomicandreceptorimplicationsanoverviewofdiagnosticandimmunologybreakthroughs
AT giannadipalma sarscov2diseasethroughviralgenomicandreceptorimplicationsanoverviewofdiagnosticandimmunologybreakthroughs